Microbot Medical Inc (NASDAQ:MBOT) shares are trading higher by 22% to $2.58 during Monday’s session after the company announced it sold 4.26 million shares under an ATM agreement and generated $4.82 ...
) has been revised to $8.92 / share. This is a decrease of 27.08% from the prior estimate of $12.24 dated November 14, 2025. The price target is an average of many targets provided by analysts. The ...
View Microbot Medical Inc MBOT stock quote prices, financial information, real-time forecasts, and company news from CNN.
Hosted on MSN
B Riley Securities initiates coverage of Microbot Medical (MBOT) with buy recommendation
Fintel reports that on February 10, 2026, B. Riley Securities initiated coverage of Microbot Medical (NasdaqCM:MBOT) with a Buy recommendation. Analyst Price Forecast Suggests 315.76% Upside As of ...
Microbot Medical Inc. MBOT recently announced that it has submitted a 510(k) premarket notification to the FDA for its LIBERTY system. The 510(k) submission follows the successful completion of its ...
Microbot Medical Inc. MBOT recently signed a clinical trial agreement with the Baptist Hospital of Miami for its LIBERTY Endovascular Robotic Surgical System. The company has received the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results